HeartWare gets US FDA nod for IDE enrollment in bridge-to-transplant trial ... pharmabiz.com HeartWare International Inc., a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, has received the US Food and Drug Administration (FDA) approval for an ... |
